Abstract
Background: Persons with basal cell skin cancer (BCSC) have shown increased risk of developing cancer at several other sites.
Methods: We identified 3164 persons with BCSC and 15,730 comparison subjects matched for age, sex, race, residence area and length of membership in a health maintenance organization.
Results: In retrospective follow-up for up to 24 years (mean 11.3 years), BCSC patients experienced statistically significant increases in the incidence of all cancer (relative risk [RR] = 1.2, 95% confidence interval [CI] = 1.1–1.4) lung cancer (RR = 1.4, CI = 1.0–1.8) and melanoma (RR = 2.2, CI = 1.6–3.0). Women experienced significantly increased risk for all cancer, lung cancer, melanoma and thyroid cancer, increases of borderline significance in breast cancer, non-Hodgkin's lymphoma and leukemia, and increased pre-existing bladder cancer. Men showed statistically significant increases in all cancer, melanoma, and kidney cancers, and mouth and throat cancers. Multivariate analysis incorporating available risk factor data did not weaken positive associations with BCSC except slightly for melanoma and for bladder cancer in women. Other previously reported associations were not confirmed.
Conclusion: Periodic skin examinations appear well justified after removal of BCSC to detect new skin cancers including melanoma. Given the relatively weak, unexplained associations of BCSC with internal cancers, the costs vs. benefits of extra efforts to detect the latter still need to be determined.
Similar content being viewed by others
References
Lindelöf B, Sigurgeirsson B, Wallberg P, Eklund G (1991) Occurrence of other malignancies in 1973 patients with basal cell carcinoma. J Am Acad Dermatol 25: 245–248.
Frisch M, Hjalgrim H, Olsen JH, Melbye M (1996) Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Intern Med 125: 815–821.
Schottenfeld D (1996) Basal-cell carcinoma of the skin: a harbinger of cutaneous and noncutaneous multiple primary cancer. Ann Intern Med 125: 852–854.
Kahn HS, Tatham LM, Patel AV, Thun MJ, Heath CW Jr (1998) Increased cancer mortality following a history of nonmelanoma skin cancer. JAMA 280: 910–912.
Levi F, La Vecchia C, Te VC, Randimbison L, Erler G (1998) Incidence of invasive cancers following basal cell skin cancer. Am J Epidemiol 147: 722–726.
Sandström A, Larsson LG, Damber L (1984) Occurrence of other malignancies in patients treated for basal cell carcinoma of the skin. A cohort study. Acta Radiol Oncol 23: 227–230.
Chute CG, Chuang TY, Bergstralh EJ, Su WP (1991) The subsequent risk of internal cancer with Bowen's disease. A population-based study. JAMA 266: 816–819.
Karagas MR, Greenberg ER, Mott LA, Baron JA, Ernster VL (1998) Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer. Cancer Epidemiol Biomarkers Prev 7: 157–161.
Hiatt RA, Friedman GD (1982) The frequency of kidney and urinary tract diseases in a defined population. Kidney Int 22: 63–68.
Krieger N (1992) Overcoming the absence of socioeconomic data in medical records. Am J Public Health 82: 703–710.
Friedman GD, Quesenberry CP Jr (1999) Spousal concordance for cancer incidence: a cohort study. Cancer 86: 2413–2419.
Collen MF, Davis LF (1969) The multitest laboratory in health care. J Occup Med 11: 355–360.
Friedman GD (1994) Kaiser Permanente Medical Care Program: Northern California and other regions. In: Strom BL, ed. Pharmacoepidemiology: The Science of Postmarketing Drug Surveillance, 2nd edn. New York: John Wiley & Sons, 187–197.
Breslow NE, Day NE (1987) Statistical Methods in Cancer Research, Vol. II: Design and analysis of cohort studies. In: Heseltine E, ed. IARC Scientific Publications; No. 82. Lyon: International Agency for Research on Cancer; New York: Distributed in US by Oxford University Press, Tables 7.4, 7.5.
Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15: 361–387.
Halpern AC, Myskowski PL (1999) Malignant cutaneous tumors. In: Dale DC, Federman DD, eds. Scientific American Medicine. New York: Scientific American, Inc., pp. 2–1–2–12.
Cartwright R, McNally R, Staines A (1994) The increasing incidence of non-Hodgkin's lymphoma (NHL): the possible role of sunlight. Leuk Lymphoma 14: 387–394.
McMichael AJ, Giles GG (1996) Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma? Br J Cancer 73: 945–950.
Hartge P, Devesa SS, Grauman D, Fears TR, Fraumeni JF Jr (1996) Non-Hodgkin's lymphoma and sunlight. J Natl Cancer Inst 88: 298–300.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Friedman, G.D., Tekawa, I.S. Association of basal cell skin cancers with other cancers (United States). Cancer Causes Control 11, 891–897 (2000). https://doi.org/10.1023/A:1026591016153
Issue Date:
DOI: https://doi.org/10.1023/A:1026591016153